Retrospective Analysis of Severe Dengue by Dengue Virus Serotypes in a Population with Social Security, Mexico 2023

Author:

Hernández Bautista Porfirio Felipe1,Cabrera Gaytán David Alejandro1ORCID,Santacruz Tinoco Clara Esperanza1,Vallejos Parás Alfonso2ORCID,Alvarado Yaah Julio Elias1,Martínez Miguel Bernardo1,Anguiano Hernández Yu Mei1,Arriaga Nieto Lumumba2ORCID,Moctezuma Paz Alejandro3,Jaimes Betancourt Leticia4,Pérez Andrade Yadira2,Orozco Oscar Cruz2,Valle Alvarado Gabriel2,Rivera Mahey Mónica Grisel2

Affiliation:

1. Coordinación de Calidad de Insumos y Laboratorios Especializados, Instituto Mexicano del Seguro Social, Ciudad de México 07760, Mexico

2. Coordinación de Vigilancia Epidemiológica, Instituto Mexicano del Seguro Social, Ciudad de México 03100, Mexico

3. Coordinación de Investigación en Salud, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico

4. Unidad de Medicina Familiar No. 7, Instituto Mexicano del Seguro Social, Ciudad de México 14370, Mexico

Abstract

Background: Risk factors for severe dengue manifestations have been attributed to various factors, including specific serotypes, sex, and age. Mexico has seen the re-emergence of DENV-3, which has not circulated in a decade. Objective: To describe dengue serotypes by age, sex, and their association with disease severity in dengue-positive serum samples from epidemiological surveillance system units. Materials and Methods: A descriptive analysis was conducted to evaluate the frequency of dengue severity by sex, age, disease quarter, geographical location, and dengue virus serotypes. The study was conducted using laboratory samples from confirmed dengue cases through RT-qPCR from the epidemiological surveillance laboratory network of the Mexican Social Security Institute, Mexico. Simple frequencies and proportions were calculated using the z-test for proportional differences between groups. Bivariate analysis with adjusted Chi2 was performed, and binary logistic regression models were constructed using the forward Wald method considering the model’s predictive capacity. The measure of association was the odds ratio, with 95% confidence intervals. Statistical significance was set to an alpha level of <0.05. Results: In 2023, 10,441 samples were processed for dengue RT-qPCR at the IMSS, with a predominance of serotype DENV-3 (64.4%). The samples were mostly from women (52.0%) and outpatient cases (63.3%). The distribution of dengue severity showed significant variations by age, with a lower proportion of severe cases in young children and a higher proportion in the 5- to 14-year-old group. Hospitalizations increased significantly with severity. Warm regions had more cases overall and severity. Cases were most frequent from July to September. While DENV-2 was associated with severity, DENV-4 was not. Binary regression identified higher risk in women, age extremes, and DENV-2, with an overall predictive model of 58.5%. Conclusions: Women, age groups at the extremes of life, and the DENV-2 serotype presented severe risk of dengue in a population with social security in Mexico during 2023.

Publisher

MDPI AG

Reference18 articles.

1. Trends of Dengue Disease Epidemiology;Cucunawangsih;Virol. Res. Treat.,2017

2. Dengue, chikungunya, and Zika virus infections in Latin America and the Caribbean: A systematic review;Santos;Rev. Panam. Salud Publica,2023

3. Lethal Dengue Virus Infection: A Forensic Overview;Byard;Am. J. Forensic. Med. Pathol.,2016

4. Dengue: A continuing global threat;Guzman;Nat. Rev. Microbiol.,2010

5. WHO (2024, April 24). Dengue—Situación Mundial. Available online: https://www.who.int/es/emergencies/disease-outbreak-news/item/2023-DON498#:~:text=Desde%20principios%20de%202023%2C%20la,OMS%3A%20%C3%81frica%2C%20las%20Am%C3%A9ricas%2C.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3